A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate the safety and effectiveness of an investigational glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Latanoprost; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol; Travoprost

Criteria

Inclusion Criteria:

• 18 years or older.

• Diagnosis of open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.

• Mean intraocular pressure (IOP) in at least one eye greater than 21 mmHg and less than or equal to 36 mmHg at screening visit.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Pregnant

• History of chronic or recurrent severe inflammatory eye disease.

• History of ocular infection or ocular inflammation within the past three months in either eye.

• Other protocol-defined exclusion criteria may apply.